Eric Lawitz, M.D., Alessandra Mangia, M viagra norge .D., David Wyles, M.D., Maribel Rodriguez-Torres, M.D., Tarek Hassanein, M.D., Stuart C. Gordon, M.D., Michael Schultz, M.D., Ph.D., Mitchell N. Davis, D.O., Zeid Kayali, M.D., K. Rajender Reddy, M.D., Ira M. Jacobson, M.D., Kris V. Kowdley, M.D., Lisa Nyberg, M.D., G. Mani Subramanian, M.D., Ph.D., Robert H. Hyland, D.Phil., Sarah Arterburn, M.S., Deyuan Jiang, Ph.D., John McNally, Ph.D., Diana Brainard, M.D., William T. Symonds, Pharm.D., John G. McHutchison, M.D., Aasim M. Sheikh, M.D., Zobair Younossi, M.D., M.P.H., and Edward J. Gane, M.D.: Sofosbuvir for Previously Untreated Chronic Hepatitis C Illness As much as 170 million persons are chronically infected with the hepatitis C virus worldwide, and more than 350,000 die yearly from liver disease due to HCV.1,2 Estimates of the real number of persons in the United States who have chronic HCV infection range between 2.7 million to 5.2 million.3,4 For previously untreated cases of HCV genotype 1 infection , the existing standard of care is 12 to 32 weeks of an oral protease inhibitor combined with 24 to 48 weeks of peginterferon alfa-2a as well as ribavirin, with the duration of therapy guided by the on-treatment response and the stage of hepatic fibrosis.8 Although 60 to 80 percent of previously untreated individuals who undergo treatment with these regimens in clinical trials experienced a sustained virologic response,6,7,9,10 a large number of patients go untreated owing to absolute and relative contraindications or unwillingness to receive interferon.

Unlike prescription medications, most herbal products do not have to currently be examined for quality, protection and efficacy. As a result, the quality and power of herbal products may differ. This can result in varying protection end efficacy. In addition, reliable information about the merchandise may be hard to find, which can lead to questions on safety and effectiveness also. An interview with Dr Matt SilverAccording to the results, women were much more likely to use herbal products if indeed they had been aged over 40 . In comparison to similar tests done in Norway, the USA and Australia, researchers also found the level to which herbal products are used in the UK was considerably higher.